The National Medical Weight Loss Programme (NMWLP) uses an FDA approved medication, which is licensed for weight management. The medication has passed numerous clinical trials for safety and is the only approved injectable prescription medicine available in the UK for weight management.
With our weight loss programme, adding the medication to a sensible meal and exercise plan helps you lose weight and keep it off.
The active ingredient is the same product used by all other weight loss injections and programmes, such as ‘skinnyjab’, ‘skinny pen’, ‘weight loss jab’, ‘skinny revolution’ etc.
As well as helping patients lose weight, The prescription medication has shown in clinical studies to improve many cardiovascular co-morbidities, such as pre-diabetes, hypertension, high lipid levels and obstructive sleep apnoea.
Clinical studies and real-world studies have shown patients who have commenced this specific weight loss program achieve significantly more weight loss and keep that weight off compared to patients who are just dieting.
The NMWLP uses prescription medication. You must complete a medical assessment with our NIP Kirsten whom will carry out a comprehensive consultation to ensure you are the right candidate & it is safe for you to use it.
The NMWLP uses a medication that is prescribed for weight management. It is used in conjunction with diet and exercise in adults aged 18 - 75, who have a BMI of 30 or above, or a BMI of 27 when there are any other weight-related health issues present such as high blood pressure, abnormal levels of fats in the blood (lipids), or breathing problems during sleep (obstructive sleep apnoea).
The medication will work as an appetite suppressant. Delivery is via a virtually painless injection taken daily or weekly, that messaging system is activated. It then makes you feel less hungry, feel fuller quicker and fuller for longer. This should lead to significant weight loss.
• Control your appetite
• Curb hunger
• Suppress cravings
• Reduce portion sizes
• Release stored fat
• Weight management
• Develop positive habits
The medication will work as an appetite suppressant. It contains the active ingredient Liraglutide, which is a Glucogon-Like Peptide-1 (GLP-1) analogue. GLP-1 is produced naturally in the human body after food is consumed. Liraglutide is 97% similar to the one our body naturally produces. In simple terms, The medication is a messaging system to tell your body that you are full and no more food is required. The medication is a virtually painless injection taken daily or weekly, that messaging system is activated. It then makes you feel less hungry, feel fuller quicker and fuller for longer. This should lead to significant weight loss.
As with any new medication, following the NMWLP may result in some short-term side effects. The most common side effects are nausea, vomiting, indigestion, constipation or diarrhoea. However, these usually settle within the first few days. Please remember, our team is always on hand to answer any questions or concerns you may have.
• Pregnant, trying to get pregnant or breast feeding
• Inflammatory bowel disease
• History of thyroid cancer
• History of pancreatitis
• Severe kidney disease
• Severe heart failure
• Taking insulin.
Each Pen contains 18mg of liraglutide. Every patient starts on 0.6mg daily for the first week. If the desired outcomes are achieved on this dose i.e. not feeling hungry or craving things (so you don’t cheat on your diet) then this dose can be maintained. If on the other hand, your appetite is not fully controlled, then the dose should be increased by 0.6mg per day for a further week. This pattern can be repeated each week until the desired effects are achieved, but only up to a maximum of 3.0mg daily.
One pen can last up to 4 weeks depending on the daily dose required to achieve the desired outcomes.
Our NIP can offer advice via Virtual Consultation . The Nurse Practitioner will gather necessary data to assess if this is the correct program for you & if you are a suitable candidate for the National Weight Loss Program
If you are the correct candidate to commence this program, the Fresh inc. team are always on hand to offer you support & answer any questions or queries you may have.
Initial fee will be £295, a comprehensive consultation & various health checks must be carried out prior to commencing our program. Further costs vary dependant on treatment needs and delivery method.
Weekly Pen – from £215